4th Global Congress on Sickle Cell Disease From 16 to 18 June 2022

Join Biomaneo & Shimadzu at the 4th Global Congress on Sickle Cell Disease taking place in Paris from June 16-18. 

Et ne manquez pas notre dernier webinaire en collaboration avec Shimadzu présentant nos solutions NeoSickle et NeoHemog sur le spectromètre de masse MALDI-8020.

The slideshow of the webinar is available in preview on youtube (see the video below)

NeoSickle – NeoHemog

« The two analytical solutions for a public health need:
A high throughput screening and diagnosis of hemoglobin (Hb) disorders
(Sickle cell disease – Thalassemia – Hemoglobin variants)
using a MALDI-8020 mass spectrometer. »

Take the opportunity to discuss with Patrick Ducoroy (CEO of Biomaneo) & Réda HAMOUR (Sales Manager Mass Spectrometry at Shimadzu France).